Managing Hard-To-Treat Areas in Psoriasis with Ixekizumab
The UNCOVER-3 trial is a recent study that has demonstrated that ixekizumab, a biologic treatment for moderate-to-severe plaque psoriasis, is effective in managing psoriasis across challenging body areas including the scalp, face, palmoplantar surfaces, or nails.
